StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Core Gross Profit by Quarter

Core Gross Profit ($M)

QuarterlyAnnual

Novartis Core Gross Profit: $12,151M in Q3 2026, up 5.6% from a year earlier. That is the highest of the 34 quarters on record here.

Latest, Q3 2026
12,151
Period ended Sep 30, 2026
Change on a year earlier
+5.6%
11,511 in Q3 2025
History
34 quarters
Since Q4 2017
Sources
26
Documents cited below

Where the Q3 2026 figure comes from

“|| Gross profit | 11 421 | 695 | 35 | 12 151 | 11 511”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCore Gross Profit ($M)Year on yearSource
Q3 2026Sep 30, 202612,151+5.6%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 202611,965+0.4%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 202610,780-2.7%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 202511,007+0.3%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 202511,511+7.9%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2025Jun 30, 202511,915+14.3%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2025Mar 31, 202511,082+13.1%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2024Dec 31, 202410,974–Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2024Sep 30, 202410,669–Novartis Form 6-K (0001114448-25-000003) ↗
Q2 2024Jun 30, 202410,427+521,250.0%Novartis Form 6-K (0001370368-25-000012) ↗
Q1 2024Mar 31, 20249,802+195,940.0%Novartis Form 6-K (0001370368-25-000010) ↗
Q2 2023Jun 30, 20232-33.3%Novartis Form 6-K (0001370368-23-000059) ↗
Q1 2023Mar 31, 20235-85.3%Novartis Form 6-K (0001370368-23-000046) ↗
Q4 2022Dec 31, 2022-1-107.1%Novartis Form 6-K (0001370368-23-000008) ↗
Q3 2022Sep 30, 20221-95.2%Novartis Form 6-K (0001370368-22-000077) ↗
Q2 2022Jun 30, 20223-83.3%Novartis Form 6-K (0001370368-23-000059) ↗

Cite this data

StockData. (2026). Novartis Core Gross Profit ($M), quarterly Q4 2017–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/core-gross-profit

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.